These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 8933041)
21. Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up. Cloeren M; Dement J; Gaitens J; Hines S; Diaz L; Tembunde Y; Cranford K; Shorter J; Mosier T; Ringen K; Am J Ind Med; 2022 Sep; 65(9):708-720. PubMed ID: 35833586 [TBL] [Abstract][Full Text] [Related]
22. Interstitial pneumonia in a glassblower: think to chronic beryllium disease! Jamoussi A; Merhabene T; Mlika M; Neji H; El Mezni F; Khelil JB; Besbes M Pan Afr Med J; 2018; 31():95. PubMed ID: 31011396 [TBL] [Abstract][Full Text] [Related]
24. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Saltini C; Richeldi L; Losi M; Amicosante M; Voorter C; van den Berg-Loonen E; Dweik RA; Wiedemann HP; Deubner DC; Tinelli C Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. Newman LS; Mroz MM; Maier LA; Daniloff EM; Balkissoon R J Occup Environ Med; 2001 Mar; 43(3):231-7. PubMed ID: 11285871 [TBL] [Abstract][Full Text] [Related]
26. Statistical methods for the blood beryllium lymphocyte proliferation test. Frome EL; Smith MH; Littlefield LG; Neubert RL; Colyer SP Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):957-68. PubMed ID: 8933042 [TBL] [Abstract][Full Text] [Related]
27. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Balmes JR; Abraham JL; Dweik RA; Fireman E; Fontenot AP; Maier LA; Muller-Quernheim J; Ostiguy G; Pepper LD; Saltini C; Schuler CR; Takaro TK; Wambach PF; Am J Respir Crit Care Med; 2014 Nov; 190(10):e34-59. PubMed ID: 25398119 [TBL] [Abstract][Full Text] [Related]
28. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290 [TBL] [Abstract][Full Text] [Related]
29. Systematic review: Progression of beryllium sensitization to chronic beryllium disease. Seidler A; Euler U; Müller-Quernheim J; Gaede KI; Latza U; Groneberg D; Letzel S Occup Med (Lond); 2012 Oct; 62(7):506-13. PubMed ID: 22705916 [TBL] [Abstract][Full Text] [Related]
30. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers. Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270 [TBL] [Abstract][Full Text] [Related]
31. The role of lymphocyte proliferation tests in assessing occupational sensitization and disease. Hines SE; Pacheco K; Maier LA Curr Opin Allergy Clin Immunol; 2012 Apr; 12(2):102-10. PubMed ID: 22306552 [TBL] [Abstract][Full Text] [Related]
32. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. McCleskey TM; Buchner V; Field RW; Scott BL Rev Environ Health; 2009; 24(2):75-115. PubMed ID: 19658317 [TBL] [Abstract][Full Text] [Related]
33. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity. Milovanova TN Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032 [TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of beryllium sensitized workers from a single employer. Duggal M; Deubner DC; Curtis AM; Cullen MR BMC Public Health; 2010 Jan; 10():5. PubMed ID: 20047684 [TBL] [Abstract][Full Text] [Related]
35. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785 [TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy of a program to prevent beryllium disease. Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749 [TBL] [Abstract][Full Text] [Related]
37. Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada. Ribeiro M; Fritscher LG; Al-Musaed AM; Balter MS; Hoffstein V; Mazer BD; Maier LA; Liss GM; Tarlo SM Lung; 2011 Jun; 189(3):233-41. PubMed ID: 21400234 [TBL] [Abstract][Full Text] [Related]
38. Beryllium disease among construction trade workers at Department of Energy nuclear sites. Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247 [TBL] [Abstract][Full Text] [Related]
39. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: an evidence-based assessment. Borak J; Woolf SH; Fields CA J Occup Environ Med; 2006 Sep; 48(9):937-47. PubMed ID: 16966961 [TBL] [Abstract][Full Text] [Related]
40. [Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (Part 2)]. Marchand-Adam S; Guillon F; Brauner M; Valeyre D Rev Mal Respir; 2005 Apr; 22(2 Pt 1):271-87. PubMed ID: 16092165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]